SPYRE THERAPEUTICS INC (SYRE:NASDAQ)
$51.29 -0.48 (-0.9272%)
Analysed SPYRE THERAPEUTICS INC (SYRE:NASDAQ) News Sources
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026
10-04-2026
yahoo.com
Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data Nears
08-04-2026
fool.com
Spyre Therapeutics Announces Grants of Inducement Awards
03-04-2026
yahoo.com
Damora Therapeutics (DMRA) Overhauls Leadership: Is Its Capital Strategy About To Quietly Shift?
01-04-2026
yahoo.com
Assessing Spyre Therapeutics (SYRE) Valuation After Strong One Year Return And Premium Price To Book Ratio
22-03-2026
yahoo.com
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools
19-03-2026
fool.com
Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
16-03-2026
yahoo.com
VR Adviser Adds Over 1 Million Savara Shares
15-03-2026
fool.com
Assessing Spyre Therapeutics (SYRE) Valuation After A Year Of Strong Shareholder Returns
05-03-2026
yahoo.com
Spyre Therapeutics to Participate in Upcoming March Investor Conferences
24-02-2026
yahoo.com
What is the current price of SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The current price of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is $51.29.
SPYRE THERAPEUTICS INC (SYRE:NASDAQ) absolute price change since previous trading day?
The absolute price change of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) since the previous trading day is $-0.48.
SPYRE THERAPEUTICS INC (SYRE:NASDAQ) percentage price change since previous trading day?
The percentage price change of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) since the previous trading day is -0.9272%.
What is the most recent average sentiment score for SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The most recent average sentiment score for SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The most recent sentiment for SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is .
SEC-8K** Filing Available For SPYRE THERAPEUTICS INC (SYRE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.